Skip to content

Original Research

Frontiers in Urology ·

Volume 6 - 2026 | https://doi.org/10.3389/fruro.2026.1926391

Association of sperm DNA fragmentation with abstinence duration, seminal oxidative stress and age: a call to consider abstinence in andrological diagnostics

  • Ralf Henkel1,2*corresponding author
  • Mohamed Arafa3,4,5
  • Ahmad Majzoub3,4
  • Haitham El Bardisi3,4,6
  • Mausumi Das7,8
  1. 1LogixX Fertility, Theale, Berkshire, United Kingdom
  2. 2Department of Medical Bioscience, University of the Western Cape, Bellville, South Africa
  3. 3Department of Urology, Hamad Medical Corporation, Doha, Qatar
  4. 4Department of Urology, Weill Cornell Medicine-Qatar, Doha, Qatar
  5. 5Department of Andrology, Cairo University, Cairo, Egypt
  6. 6College of Medicine, Qatar University, Doha, Qatar
  7. 7Glasgow Royal Infirmary & University of Glasgow, Glasgow, United Kingdom
  8. 8Chelsea and Westminster Hospital, Assisted Conception Unit, Imperial College, London, United Kingdom
Article metrics0 viewsView details

Abstract

According to World Health Organization (WHO) recommendations, the abstinence period for a semen analysis is 2 to 7 days. Other professional medical societies recommend shorter abstinence periods. Since sperm DNA fragmentation (SDF) is positively associated with oxidative stress, age and abstinence, this study aimed at investigating a threshold of abstinence for the diagnostic use of SDF testing. In this retrospective study, SDF (HaloSperm) and oxidative stress (MiOXSYS) were tested in 2782 consecutive patients, attending the Department of Urology at Hamad Medical Corporation in Doha, Qatar. Patients were stratified according to the abstinence. Results showed significant trends of higher SDF and oxidative stress with longer periods of abstinence. ROC curve analysis with 20% SDF as classification variable resulted in thresholds of >4 days for abstinence, >37 years for age and 59.9 mV for oxidation-reduction potential. Multiple linear regression analysis revealed abstinence, age and oxidative stress as strong independent predictors of high SDF. When requesting and interpreting an SDF test, abstinence, age and oxidative stress have to be considered. A maximum of 4 days of abstinence is recommended.

Keywords

Introduction

According to the definition of the World Health Organization (WHO), infertility is a disease where a couple does not achieve pregnancy after at least 12 months of regular unprotected sexual intercourse (1). Globally, an estimated one in six people suffer from infertility at some stage in their lifetime, with approximately half of the cases caused or contributed to by the male partner. Since this disease has significant adverse effects on general health, mental and psychological well-being, as well as finances and the relationship of affected couples (2–5), even leading to social stigma, depression, domestic violence and divorce (6, 7), infertility must be recognised as a globally under-recognised public health problem (8).

In the andrological workup, the semen analysis according to WHO guidelines (9) is the primary diagnostic tool for identifying male factor infertility. Apart from semen volume and viscosity, this widely standardized analysis examines basic semen parameters such as sperm concentration, motility, normal sperm morphology and sperm viability. Today, despite its limitations and repeated criticism (10–13), the standard semen analysis is still the cornerstone of andrological fertility diagnosis (14).

As part of an extended and advanced examination, the “WHO laboratory manual for the examination and processing of human semen” suggests testing for sperm DNA fragmentation (SDF) and seminal oxidative stress, respectively, as they have emerged as clinical biomarkers of male infertility. Oxidative stress and elevated SDF are intricately linked and have been associated with poor reproductive outcomes after different methods of assisted reproduction, including pregnancy loss (15–18).

However, despite all the standardization, for the period of sexual abstinence, which has been shown to influence semen quality and consequently clinical decision-making as well as reproductive outcomes (19–23), a range of between 2 and 7 days of ejaculatory abstinence is recommended. The American Urological Association (AUA), American Society of Reproductive Medicine (ASRM) and the European Association of Urology (EAU) also follow this recommendation by the WHO. On the other hand, the Nordic Association for Andrology (NAFA) and the European Society of Human Reproduction and Embryology (ESHRE) Special Interest of Andrology Group, recommend a narrower range of 3 to 4 days of ejaculatory abstinence (24).

Although numerous articles investigating the effects of ejaculatory abstinence on semen parameters have been published thus far (21, 25), insufficient information is available about the ideal period of sexual abstinence for normal SDF. SDF is positively associated with seminal oxidative stress, age and the duration of sexual abstinence (26–28) and may therefore be influenced by these parameters. Consequently, positive or negative outcomes of SDF testing may affect the clinical management of patients. Therefore, this study aims to investigate an ideal period of abstinence for normal SDF, considering oxidative stress and the patients’ age as confounding factors.

Materials and methods

Patients

In this retrospective cohort study, semen analyses, seminal oxidative stress and sperm DNA fragmentation of a total of 2782 consecutive patients, aged between 18 and 73 years, attending the infertility unit at the Department of Urology at Hamad Medical Corporation in Doha, Qatar, for fertility evaluation, between January 2016 and January 2018 were analysed. Otherwise, no additional inclusion or exclusion criteria were used.

The study was approved by the Ethics Committee of the Medical Research Center of Hamad Medical Corporation. A waiver of informed consent was obtained for this study.

Semen analysis

Semen samples were collected in sterile plastic containers after times of sexual abstinence between 1 and 10 days. After liquefaction of the samples for 30 minutes at 37 °C, a standard semen analysis was performed according to the fifth Edition of the WHO Laboratory Manual for the Examination and Processing of Human Semen (29).

Determination of sperm DNA fragmentation

SDF was determined by using the Halosperm G2 test (Halotech DNA SL, Madrid, Spain) according to the manufacturer’s instruction. In brief, a semen sample was diluted with phosphate-buffered saline to adjust the sperm concentration to a maximum of 20×106 sperm/mL. Thereafter, 50 µL of this suspension were mixed with low-melting-point agarose and 8 µL of the suspension placed on a slide and covered with a coverslip. After the agarose-sperm suspension was solidified, the coverslip was removed and the sample denatured, lysed and stained. Subsequently, excess stain was washed off and the slide evaluated in a brightfield microscope. Sperm with intact DNA produce a dispersion halo while those with fragmented DNA do not produce such a halo or only a much smaller halo of a size up to one third of the core diameter (30). Since an SDF level of >20% is generally accepted as high, we also used this threshold (31–33).

Determination of seminal oxidative stress

For the measurement of the seminal OS, the MiOXSYS® system (Aytu BioScience, Englewood, CO) was used. In brief, 30 µL of liquefied semen were placed on the sample port of the sensor. The static oxidation-reduction potential (sORP) was displayed after approximately 4 minutes. For the analyses in this study, the actual ORP readings in milli Volts (mV) and the normalized values (normalized ORP) expressed as mV/106 sperm/mL were recorded (34).

Statistical analysis

For the statistical analyses, MedCalc Statistical Software (v 23.5.5; MedCalc Software Ltd., Ostend, Belgium) was used. After testing for normal distribution with the Shapiro-Wilk test, data was expressed as mean ± SD and median with interquartile range (IQR). Non-parametric tests (Spearman rank correlation and Mann-Whitney test), Chi-squared test, and Kruskal-Wallis test with subsequent Jonckheere-Terpstra trend test were conducted. Patients were stratified as into 4 groups of sexual abstinence (1 to 2 days, 3 to 4 days, 5 to 6 days, and 7 or more days) according to Ayad et al. (35). ROC curve analyses for abstinence, age, sORP, sperm concentration and the total number of DNA-damaged sperm were performed with an SDF threshold of >20% as classification criterion. For the investigation of the effects of causative/contributing factors (age, sexual abstinence and oxidative stress) to SDF, odds ratios (OR) were calculated using the Cochrane-Mantel-Haenszel test and multiple linear regression analysis with variables entered into the model using the backward method.

Since not all parameters were investigated for all (n=2782) patients, lower numbers were recorded for ejaculate volume, SDF, total number of DNA-damaged sperm, morphology, sORP, normalized ORP, total and progressive motility, and vitality.

A P-value of P<0.05 was considered significant.

Results

Table 1 shows the patients’ summary statistics of this study while Table 2 provides results of Spearman Rank correlations between the various parameters taken in this study. While normal sperm morphology showed no association with any of the investigated parameters, all other variables were associated. Specifically, the duration of ejaculatory abstinence showed significant positive correlations with sperm concentration, ejaculate volume, SDF, the total number of DNA-damaged sperm, sORP, and total motility. SDF and sORP were significantly associated with all parameters except normal sperm morphology and ejaculate volume, and age and morphology, respectively.

Table 1. Summary statistics.

nMinimumMaximumMeanMedianSDIQR
Abstinence (d)27821.0010.003.883.001.633.00 to 5.00
Age (yrs)278218.0073.0035.8535.007.7530.00 to 40.00
Conc. (106/ml)27820.60160.0032.5628.0025.5412.00 to 47.00
Ejaculate volume (mL)27810.5027.003.002.501.732.00 to 4.00
SDF (%)7625.00100.0029.2225.0019.0615.00 to 37.00
Total Number of DNA-damaged Sperm (106)7610.578378.0028.6915.8438.377.33 to 35.00
Total Number of Motile DNA-damaged Sperm (106)7600.00151.2012.947.4916.413.51 to 15.08
Normal Morphology (%)7910.00100.004.814.007.312.00 to 5.00
Normalized ORP (mV/106 sperm/mL)2781-6.33222.075.171.8810.461.00 to 4.38
Progr. Motility (%)27810.0050.0011.4410.0011.510.00 to 20.00
sORP (mV)2781-65.30666.2056.7450.9037.3737.38 to 68.73
Total Motility (%)27700.00100.0047.5150.0018.6640.00 to 60.00
Vitality (%)6040.0096.0046.0848.0019.3732.00 to 60.00

C, Combined data for abstinence new (updated 23.03.26) n=2783.mc1.

Table 2. Spearman Rank correlations between abstinence, age, sperm concentration, SDF, total number of DNA-damaged sperm, total and progressive motility, sORP and normalized ORP, normal sperm morphology, ejaculate volume, and sperm viability.

Abstinence (d)Age (yrs)Conc. (106/ml)Ejaculate volume (ml)SDF (%)Total number of DNA-damaged sperm (106)Normal sperm morphology (%)sORP (mV)Normalized ORP (mV/106 sperm/mL)Total motility (%)Progr. motility (%)
Age (yrs)r0.0241
P0.2138
n2782
Conc. (106/ml)r0.1000.0011
P<0.00010.9738
n27822782
Ejaculate Volume (ml)r0.168-0.098-0.0471
P<0.0001<0.00010.0124
n278127812781
SDF (%)r0.1240.178-0.1120.0601
P0.0006<0.00010.00200.0992
n762762762761
Total Number of DNA-damaged Sperm (106)r0.2440.0080.6060.4940.4941
P<0.00010.8175<0.0001<0.0001<0.0001
n761761761761761
Normal sperm morphology (%)r-0.017-0.0370.001-0.005-0.0060.0371
P0.64220.29980.96680.89940.92550.5946
n791791791791213213
sORP (mV)r0.1130.0310.0750.0630.1810.1680.0001
P<0.00010.10270.00010.0009<0.0001<0.00010.9916
n2781278127812780762761791
Normalized ORP (mV/106 sperm/mL)r-0.0260.013-0.8370.0760.219-0.405-0.0060.4091
P0.16920.5054<0.00010.0001<0.0001<0.00010.8565<0.0001
n27812781278127807627617912781
Total Motility (%)r-0.076-0.1230.3410.033-0.522-0.1500.005-0.124-0.3781
P0.0001<0.0001<0.00010.0830<0.0001<0.00010.8808<0.0001<0.0001
n277027702770276975375278727692769
Progr. Motility (%)r-0.020-0.0950.4460.031-0.408-0.030-0.031-0.097-0.4470.7491
P0.2957<0.0001<0.00010.0981<0.00010.40870.3825<0.0001<0.0001<0.0001
n2781278127812780761760791278027802770
Viability (%)r-0.074-0.1580.1380.011-0.723-0.3480.063-0.112-0.1660.6360.174
Pn0.07000.00010.00070.7837<0.0001<0.00010.47950.0060<0.0001<0.0001<0.0001
604604604604141141128604604602603

Tables 3 and 4 provide results after stratification for normal (≤20%)/high (>20%) SDF (Table 3) and duration of sexual abstinence (Table 4). With regard to ejaculatory abstinence, a significantly longer period of abstinence was observed for patients with high (>20%) SDF values as compared to those patients with normal SDF values (Table 3). Similarly, significantly higher values were observed for age, sORP, normalized ORP, and the total number of DNA-damaged sperm. Sperm concentration, total and progressive motility as well as viability were significantly lower in patients with high SDF than in those with normal SDF values. For the ejaculatory volume and normal sperm morphology, no difference could be noticed. Stratification of ejaculatory abstinence into 4 groups (1 to 2 days, 3 to 4 days, 5 to 6 days, and 7 or more days) showed significant trends toward higher values after longer periods of abstinence for sperm concentration, ejaculate volume, SDF, sORP, and the total number of DNA-damaged sperm (Table 4; Figure 1). Interestingly, while a highly significant positive trend was found for sORP, this was not the case for normalized ORP. For total motility and viability, the trends were negative, whereas no significant effects were observed for age, normal sperm morphology, normalized ORP, and progressive motility (Table 4).

Table 3. Comparison of duration of abstinence, age, semen variables, sperm DNA fragmentation (SDF) and ORP (sORP and normalized ORP) between patients with normal (≤20%) and high (>20%) SDF.

Categorisation for sperm DNA fragmentation
≤20%>20%P #
Abstinence (d)3.63 ± 1.48n = 3224.08 ± 1.68n = 4400.0002
Age (yrs)34.45 ± 6.57n = 32237.13 ± 8.40n = 440<0.0001
Sperm concentration (106/ml)34.72 ± 22.57n = 32231.97 ± 43.23n = 4400.0091
Ejaculate volume (mL)3.00 ± 2.03n = 3223.13 ± 1.73n = 4390.2072
SDF (%)14.26 ± 3.93n = 32240.18 ± 18.28n = 440<0.0001
Total Number of DNA-damaged Sperm (106)14.50 ± 16.78n = 32239.10 ± 45.73n = 439<0.0001
Normal Morphology (%)4.61 ± 5.26n = 1094.17 ± 3.84n = 1040.5197
Normalized ORP (mV/106 sperm/mL)2.55 ± 3.46n = 3223.47 ± 4.23n = 440<0.0001
Progr. Motility (%)15.89 ± 11.95n = 3228.37 ± 10.82n = 439<0.0001
sORP (mV)51.41 ± 24.17n = 32261.06 ± 40.19n = 4400.0018
Total Motility (%)57.69 ± 14.05n = 31643.57 ± 19.09n = 437<0.0001
Sperm viability (%)65.71 ± 16.08n = 2144.29 ± 18.53n = 120<0.0001

Means ± SD are provided.

Data are: Mean ± Standard deviation.

#Mann-Whitney test.

Table 4. Comparison of duration of abstinence, age, semen variables, sperm DNA fragmentation (SDF) and ORP (sORP and normalized ORP) between different categories of sexual abstinence.

Days of abstinence1 to 2 days3 to 4 days5 to 6 days≥ 7 daysP #TrendP ‡
Abstinence (d)1.71 ± 0.46n = 252(a)(b)(c)3.21 ± 0.41n = 1833(a)(d)5.17 ± 0.38n = 231(b)7.02 ± 0.21n = 466(c)(d)––
Age (yrs)34.92 ± 8.03n = 252(a)35.83 ± 7.54n = 183336.85 ± 7.79n = 231(a)35.92 ± 8.34n = 4660.01760.0750
Sperm concentration (106/ml)29.90 ± 23.33n = 252(a)31.10 ± 25.04n = 1833(b)34.37 ± 26.13n = 23138.84 ± 27.32n = 466(a)(b)<0.0001<0.0001
Ejaculate volume (mL)2.24 ± 1.31n = 252(a)(b)(c)2.98 ± 1.61n = 1832(a)(d)3.19 ± 1.53n = 231(b)3.43 ± 2.28n = 252(c)(d)<0.0001<0.0001
SDF (%)27.77 ± 21.09n = 60(a)27.82 ± 17.98n = 517(b)32.45 ± 21.78n = 6034.18 ± 20.23n = 125(a)(b)0.00100.0001
Total Number of DNA-damaged Sperm (106)18.74 ± 25.61n = 60(a)(b)23.93 ± 28.83n = 516(c)33.16 ± 29.17n = 60(a)50.96 ± 64.83n = 125(b)(c)<0.0001<0.0001
Normal Morphology (%)5.42 ± 7.81n = 864.64 ± 6.18n = 5023.86 ± 2.90n = 585.44 ± 10.94n = 1450.83280.5526
Normalized ORP (mV/106 sperm/mL)4.39 ± 7.45n = 2525.30 ± 10.88n = 18335.53 ± 11.35n = 2304.91 ± 9.66n = 4660.28200.2152
Progr. Motility (%)11.84 ± 11.23n = 25211.45 ± 11.53n = 183211.58 ± 11.79n = 23111.09 ± 11.48n = 4660.78930.3974
sORP (mV)52.55 ± 36.29n = 252(a)55.30 ± 37.93n = 1833(b)54.07 ± 26.83n = 23066.02 ± 38.82n = 466(a)(b)<0.0001<0.0001
Total motility (%)50.11 ± 18.26n = 251(a)47.75 ± 18.69n = 1824(b)46.38 ± 18.07n = 23045.70 ± 19.10n = 465(a)(b)0.0012<0.0001
Sperm viability (%)49.38 ± 22.03n = 47(a)46.91 ± 18.93n = 402(b)47.75 ± 19.15n = 5540.25 ± 19.10n = 100(a)(b)0.00590.0042

Means ± SD are provided.

Data are: Mean ± Standard deviation.

# Kruskal-Wallis test.

‡ Jonckheere-Terpstra test.

(a) groups with the same letter differ significantly in the post-hoc test according to Dunn.

Average age (years), sperm concentration (10<sup>6</sup>/mL), SDF (%), sORP (mv), total number of DNA-damaged sperm (10<sup>6</sup>), and ejaculate volume (mL) of patients stratified for the duration of abstinence. n=2782.
Figure 1. Average age (years), sperm concentration (106/mL), SDF (%), sORP (mv), total number of DNA-damaged sperm (106), and ejaculate volume (mL) of patients stratified for the duration of abstinence. n=2782.

ROC curve analyses to identify thresholds for sexual abstinence, age, sORP, sperm concentration, and the total number of DNA-damaged sperm using the 20% cut-off value for high SDF as a classification variable were performed (Figure 2). The calculation of a threshold value for sexual abstinence was significant (P = 0.0002) (AUC: 0.572; 95%CI: 0.536-0.607) for a threshold of 4 days with a sensitivity and specificity of 29.09% and 82.30%, respectively. For age and sORP similar AUCs were obtained (Table 5).

Comparison of the ROC curves for the predictive power of the duration of sexual abstinence, age, and sORP for high SDF (>20%). Sample size: n=762.
Figure 2. Comparison of the ROC curves for the predictive power of the duration of sexual abstinence, age, and sORP for high SDF (>20%). Sample size: n=762.

Table 5. ROC curve analyses for the predictive power of the duration of sexual abstinence, age, and sORP for norm/high SDF (>20%).

AUC95%CICut-offSensitivitySpecificityP-value
Abstinence (d)0.5720.536-0.607>4 d29.09%82.30%0.0002
Age (yrs)0.5910.555-0.626>37 yrs38.41%75.78%<0.0001
sORP (mV)0.5660.530-0.602>59.9 mV41.59%68.63%0.0016

Sample size: n=762.

Based on these cut-off values, odds ratio calculations for high SDF (>20%) revealed significantly higher probabilities for patients having elevated SDF values if the patients were sexually abstinent for more than 4 days (OR = 1.9073, P = 0.0003), had elevated sORP values (OR = 1.6640, P = 0.0008) or were older than 37 years (OR = 1.7357, P = 0.0004). When advanced age (>37 years) and higher seminal oxidative stress (>59.9 mV) as contributing factors to elevated SDF were taken in consideration, the Cochrane-Mantel-Haenszel test revealed an overall approximately two-fold higher risk of having an SDF level higher than 20% (age >37 years: OR = 2.0182; P = 0.0002). Patients with high sORP as risk factor had an overall increased odds ratio of 1.4405 (sORP >59.9 mV: P = 0.0186). Were these two confounding factors combined, the probability of high SDF values was almost three-times higher (OR = 2.8100, P<0.0001) than for young patients with normal sORP.

While the prevalence of patient presenting with an SDF level >20% after a sexual abstinence of more than 7 days was significantly (P = 0.0005) higher than after 3 to 4 days, the prevalence of high SDF after 5 to 6 days of abstinence is markedly, but not significantly (P = 0.2315) higher than after 3 to 4 days of ejaculatory abstinence (Figure 3A). For oxidative stress measured as sORP, the prevalence of elevated oxidative stress levels was significantly (P = 0.0017) higher after 7 or more days of abstinence as compared to 5 to 6 days (Figure 3B). For shorter abstinences, the differences were highly significant (P<0.0001). In contrast, no differences between the prevalence of high normalized ORP were found between the different abstinence groups (Figure 3C). The percentage of patients older than 37 years increased continuously from an ejaculatory abstinence of 1 to 2 days to an abstinence of 5 to 6 days. For the abstinence group of 7 or more days, however, the percentage was slightly, but not significantly (P = 0.4846), lower than for an abstinence of 5 to 6 days (Figure 3D).

**(A)** Prevalence of high (>20%) and normal SDF values depending on the duration of sexual abstinence. (n=762). **(B)** Prevalence of high (>1.34 mV/10<sup>6</sup> sperm/mL) and normal (≤1.34 mV/10<sup>6</sup> sperm/mL) normalized ORP depending on the duration of sexual abstinence. (n=2781). **(C)** Prevalence of high (>59.9 mV) and normal (≤59.9 mV) sORP depending on the duration of sexual abstinence. (n=2781). **(D)** Prevalence of patients >37 years and ≤37 years depending on the duration of sexual abstinence. (n=2781).
Figure 3. (A) Prevalence of high (>20%) and normal SDF values depending on the duration of sexual abstinence. (n=762). (B) Prevalence of high (>1.34 mV/106 sperm/mL) and normal (≤1.34 mV/106 sperm/mL) normalized ORP depending on the duration of sexual abstinence. (n=2781). (C) Prevalence of high (>59.9 mV) and normal (≤59.9 mV) sORP depending on the duration of sexual abstinence. (n=2781). (D) Prevalence of patients >37 years and ≤37 years depending on the duration of sexual abstinence. (n=2781).

Multiple linear regression analysis for high/low SDF as categorical outcome variable with the duration of abstinence, patient’s age and sORP as independent variables that can contribute to sperm DNA fragmentation revealed that age was the strongest independent predictor of elevated SDF (t=4.8993, P<0.0001), followed by abstinence (t=3.7950, P = 0.0002) and sORP (t=3.1856, P = 0.0015). However, if the percentage of DNA-fragmented sperm was used as outcome variable, sORP was the strongest independent variable (t=6.9800; P<0.0001), followed by age (t=6.4633; P<0.0001) and abstinence (t=2.8695; P = 0.0042). If the total number of DNA-damaged sperm was used as dependent variable ejaculatory abstinence contributed most to a high number of DNA-damaged sperm, whereas age was not included in the statistical model. For sORP, abstinence was the strongest predictor followed by age. The variance inflation factors (VIF) close to 1 indicate no or neglectable multicollinearity (Table 6).

Table 6. Multiple linear regression analysis for the investigation of the contribution of sexual abstinence, age, sORP, sORP/vitality, and sperm vitality to SDF.

Dependent variable: SDF ≤20% or >20% (yes-no)
Independent variablesCoefficientStd. Error95% CItPrpartialrsemipartialVIF
Dependent variable: Percentage of DNA-fragmented sperm (%)
Independent variablesCoefficientStd. Error95% CItPrpartialrsemipartialVIF
Dependent variable: Total Number of DNA-damaged sperm (106)
Independent variablesCoefficientStd. Error95% CItPrpartialrsemipartialVIF
Dependent variable: sORP (mV)
Independent variablesCoefficientStd. Error95% CItPrpartialrsemipartialVIF
(Constant)-0.07150.0965-0.2611 to 0.1180-0.74080.4591
Abstinence (d)0.04180.01100.0202 to 0.06353.79500.00020.13660.13341.019
Age (yrs)0.01100.00220.0066 to 0.01544.8993<0.00010.17520.17221.006
sORP (mV)0.00160.00050.0006 to 0.00263.18560.00150.11490.11201.018
(Constant)-2.28363.6016-9.3540 to 4.7867-0.63410.5262
Abstinence (d)1.17830.41060.3722 to 1.98442.86950.00420.10370.09761.019
Age (yrs)0.53950.08350.3756 to 0.70346.4633<0.00010.22850.21971.006
sORP (mV)0.13170.01890.0947 to 0.16876.9800<0.00010.24570.23731.018
(Constant)-3.39633.9438-11.1384 to 4.3458-0.86120.3894
Abstinence (d)5.89540.84054.253 to 7.54557.0138<0.00010.24690.24311.015
sORP (mV)0.16060.03860.0848 to 0.23654.1572<0.00010.14930.14411.015
Age (yrs)Not included in the model
(Constant)40.11613.707132.8471 to 47.385110.8214<0.0001
Abstinence (d)2.24210.43211.3948 to 3.08945.1888<0.00010.09800.09791.000
Age (yrs)0.22140.09100.0430 to 0.39982.43390.01500.04610.04591.000

By using the option of ‘backward’ entering of variables into the model (first enter all variables into the model and next remove the non-significant variables sequentially), the variable sORP/vitality was removed from the regression equation.

Discussion

The standard semen analysis according to WHO guidelines is considered a cornerstone in the assessment of the infertile male. It is a high complexity medical analysis comprising of important parameters such as sperm concentration, motility, and normal sperm morphology (14). As an extension, advanced testing for SDF and seminal oxidative stress have repeatedly been suggested in recent years (36–39). Although repeated studies, including meta-analyses, have shown SDF and oxidative stress to be predictive of fertilization, embryo development and pregnancy (40–42), the benefits of SDF and oxidative stress testing for the clinical management and reproductive outcome are still a matter of debate as these tests are viewed not essential for clinical decision-making (32, 33, 43). This might have various reasons including the lack of generally accepted methodologies with validated clinical thresholds or high inter-assay variability.

With regard to the association of the standard semen parameters with the duration of ejaculatory abstinence, our data confirm the general trend of higher values for sperm concentration and semen volume (21, 22, 44) as well as lower values for motility and viability with increasing times of sexual abstinence (23, 45, 46). Several studies have shown that extended periods of ejaculatory abstinence are associated with elevated levels of seminal oxidative stress and SDF (21, 25, 47). Results presented in this study confirm the relationships between the SDF and oxidative stress as well as the duration of ejaculatory abstinence and are consistent with the processes of sperm production, maturation, transport and storage. During extended periods of ejaculatory abstinence, sperm are stored in the epididymis, hence are exposed to reactive oxygen species (ROS) for a longer period of time (48, 49). Due to their limited intracellular repair mechanisms and extraordinary high content of polyunsaturated fatty acids in the plasma membrane (50–52), sperm are highly prone to oxidative assaults resulting in lipid peroxidation and DNA damage caused by malondialdehyde or 4-hydroxy-2-alkenals, which are highly mutagenic and genotoxic (53–55).

The WHO recommends a period of ejaculatory abstinence of 2 to 7 days prior to semen production (9), a period that has repeatedly been questioned. ESHRE suggests a much narrower range of 3 to 4 days of abstinence (24, 56). The reason for these different ranges might be because of different purposes. While the WHO manual is rather focussed on reliable diagnostic semen parameters such as sperm count or motility, the ESHRE recommendation is focused on the time window for optimum sperm functionality for in vitro fertilization (57, 58) which, as shown in this study, includes sperm DNA fragmentation.

The lack of standardized periods of sexual abstinence has direct implications for practitioners ordering an SDF test or preparing the patient for assisted reproduction. Using ROC curve analysis, this study clearly shows that abstinence periods should not exceed 4 days as the average SDF value and the prevalence of patients presenting with high SDF increased significantly after longer abstinence periods. Therefore, considering the importance of the contribution of intact DNA for a successful reproductive outcome, the period of ejaculatory abstinence should be taken into account when requesting a diagnostic SDF test. The association of shorter abstinence times, even as short as 2 hours, with reproductive outcome parameters such as fertilization, embryo development, implantation and pregnancy together with lower SDF rates has been shown (59–61).

Research showed that SDF and oxidative stress are also positively associated with the patients’ age (62–64), a result which, in this study, could only be confirmed for SDF as we did not observe any association between age and sORP and normalized ORP. Yet, considering that SDF and oxidative stress are (i) significantly associated with fertilization, embryo development and pregnancy (41, 65–68), (ii) age (63, 64, 69), and (iii) the duration of ejaculatory abstinence (25, 70, 71), the period of abstinence will have a significant effect on the use of SDF and oxidative stress as diagnostic tests and may thus influence the clinical decision making if health practitioners have to rely on the outcome of the test. Therefore, it is important to investigate the impact of age and ejaculatory abstinence as factors that can influence the outcome of oxidative stress and SDF determinations.

The general associations of SDF and oxidative stress with the duration of ejaculatory abstinence have been confirmed in this study. However, we went further and, based on the frequently used cut-off value of 20% DNA-damaged sperm in the HaloSperm test (31, 32), calculated thresholds for abstinence (>4 days), age (>37 years) and sORP (>59.9 mV). Although the calculated predictive power is only relatively weak, the prediction is highly significant which is likely due to the multifactorial causation of SDF. For the parameters investigated in this study, namely abstinence, age and sORP, multiple linear regression analysis has shown age and ejaculatory abstinence to be significant independent predictors of elevated SDF values not only of high SDF but also of seminal oxidative stress.

Seminal oxidative stress measured as sORP, the patients’ age and ejaculatory abstinence had significant influence on high SDF. This study also revealed an almost 3-times higher probability of elevated SDF values in patients older than 37 years with seminal oxidative stress. For these patients it would make sense to recommend a shorter period of abstinence and/or the supplementation with antioxidants if no other cause for the high SDF such as a genital tract infection or varicocele has been detected. Therefore, the patient’s age, oxidative stress and abstinence as contributing factors to high SDF have to be considered when interpreting the results of SDF and oxidative stress testing as well as the management of the patient. Alternatively, one could think of different optimal abstinence times for different parameters and different age groups as suggested by Chen et al. (72).

While definition of a clear upper abstinence threshold for the determination of SDF is certainly beneficial for the diagnostic and management of a patient, this study also has limitations. Since the patients were instructed to follow WHO guidelines with a period of sexual abstinence between 2 and 7 days, we only have 6 patients with a longer abstinence period in our patient cohort. Therefore, it was not possible to provide a more detailed picture of the levels of SDF and oxidative stress after longer abstinence periods. However, since both SDF and sORP significantly increased even earlier than 7 days, it is unlikely that these parameters will improve at longer periods of abstinence. Moreover, since only viable sperm are able to reach and fertilize an oocyte, and sperm viability is significantly correlated with SDF (73), the determination of SDF in viable sperm might increase accuracy and predictive value of the test as proposed by Muratori et al. (74). Another limitation is that this study is a retrospective study which did not include other factors that can cause oxidative stress such as poor lifestyle, smoking, obesity or diabetes and therefore influence SDF.

Conclusions

In conclusion, the multiple linear regression analysis in this study clearly showed that SDF is dependent on the duration of abstinence, the patients’ age and seminal oxidative stress with the dominance of the independent variable being dependent on which parameter was chosen as dependent variables, high/low SDF, percentage of DNA-fragmented sperm, or the total number of DNA-fragmented sperm. The ROC curve analysis and the analysis of the stratification of the abstinence for elevated SDF (>20%) resulted in a threshold for abstinence of a maximum of 4 days of abstinence. Considering that SDF is significantly influenced by seminal oxidative stress, patient’s age and the duration of abstinence, the study also clearly shows that these contributing factors have to be considered when requesting and interpreting an SDF test. It will also have direct impact on the management of the patients. Nevertheless, more detailed prospective studies are necessary to discern the benefits of considering ejaculatory abstinence when testing for SDF. This might be particularly important for specific patient groups such as oligozoospermic or asthenozoospermic patients.

Generative AI statement

The author(s) declared that generative AI was not used in the creation of this manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Footnotes

Edited by: Andrea Cocci, University of Florence, Italy

Reviewed by: Amr Ammar, Al-Azhar University, Egypt

Binarwan Halim, Universitas Prima Indonesia, Indonesia

Statements

Conflict of interest

Author RH is employed by LogixX Fertility.

The remaining author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Funding

The author(s) declared that financial support was not received for this work and/or its publication.

Data availability

The datasets presented in this article are not readily available because According to institutional policy clinical data cannot be shared. Requests to access the datasets should be directed to ralf.henkel@logixxfertility.com.

Ethics approval

The studies involving humans were approved by Ethics Committee of the Medical Research Center of Hamad Medical Corporation. The studies were conducted in accordance with the local legislation and institutional requirements. The ethics committee/institutional review board waived the requirement of written informed consent for participation from the participants or the participants’ legal guardians/next of kin because Patient data were also used for other analysis which was approved.

Author contributions

RH: Writing – review & editing, Formal analysis, Methodology, Writing – original draft, Software, Validation, Conceptualization, Visualization, Investigation, Data curation. MA: Resources, Investigation, Methodology, Supervision, Writing – review & editing. AM: Validation, Investigation, Writing – review & editing, Methodology. HE: Funding acquisition, Validation, Supervision, Writing – review & editing, Resources, Project administration, Methodology, Investigation. MD: Validation, Writing – review & editing.

References

  1. 1 World Health Organization. Infertility Prevalence Estimates, 1990–2021. (2023). Geneva: World Health Organization. Licence: CC BY-NC-SA 3.0 IGO.
  2. 2 Luk BHK, Loke AY. The impact of infertility on the psychological well-being, marital relationships, sexual relationships, and quality of life of couples: A systematic review. J Sex Marital Ther. (2015) 41: 610–25. doi: doi:10.1080/0092623x.2014.958789
  3. 3 Njagi P, Groot W, Arsenijevic J, Dyer S, Mburu G, Kiarie J. Economic costs of infertility care for patients in low-income and middle-income countries: a systematic review protocol. BMJ Open. (2020) 10: e042951. doi: doi:10.1136/bmjopen-2020-042951
  4. 4 Njagi P, Groot W, Arsenijevic J, Dyer S, Mburu G, Kiarie J. Financial costs of assisted reproductive technology for patients in low- and middle-income countries: a systematic review. Hum Reprod Open. (2023) 2023: hoad007. doi: doi:10.1093/hropen/hoad007
  5. 5 Njagi P, Groot W, Arsenijevic J, Mburu G, Chambers G, Calhaz-Jorge C. Financial cost of assisted reproductive technology for patients in high-income countries: A systematic review protocol. PLoS One. (2025) 20: e0318780. doi: doi:10.1371/journal.pone.0318780
  6. 6 Rutstein SO, Shah IH. Infecundity, Infertility, and Childlessness in Developing Countries. DHS Comparative Reports No. 9. (2004). Calverton, MD: ORC Macro and the World Health Organization.
  7. 7 World Health Organization. Infertility Factsheet. (2025). Available online at: https://www.who.int/news-room/fact-sheets/detail/infertility (Accessed March 27, 2026).
  8. 8 McDonald Evens E. A global perspective on infertility: An under recognized public health issue. Carolina Papers Int Health. (2004) 18: 1–42.
  9. 9 World Health Organization. WHO Laboratory Manual for the Examination and Processing of Human Semen. (2021). 6th ed. Geneva: World Health Organization. Licence: CC BY-NC-SA 3.0 IGO.
  10. 10 Wang C, Swerdloff RS. Limitations of semen analysis as a test of male fertility and anticipated needs from newer tests. Fertil Steril. (2014) 102: 1502–7. doi: doi:10.1016/j.fertnstert.2014.10.021
  11. 11 Boitrelle F, Shah R, Saleh R, Henkel R, Kandil H, Chung E. The sixth Edition of the WHO Manual for Human Semen Analysis: A critical review and SWOT analysis. Life (Basel). (2021) 11: 1368. doi: doi:10.3390/life11121368
  12. 12 Eisenberg ML. The past, present, and future of the semen analysis. Fertil Steril. (2022) 117: 235–236. doi: doi:10.1016/j.fertnstert.2021.11.031
  13. 13 Esteves SC. Evolution of the World Health Organization semen analysis manual: where are we ? Nat Rev Urol. (2022) 19: 439–46. doi: doi:10.1038/s41585-022-00593-2
  14. 14 Crafa A, Cannarella R, La Vignera S, Barbagallo F, Condorelli RA, Calogero AE. Semen analysis: A workflow for an appropriate assessment of the male fertility status. Minerva Endocrinol. (2022) 47: 77–88. doi: doi:10.23736/s2724-6507.21.03650-2
  15. 15 Esteves SC, Santi D, Simoni M. An update on clinical and surgical interventions to reduce sperm DNA fragmentation in infertile men. Andrology. (2020) 8: 53–81. doi: doi:10.1111/andr.12724
  16. 16 Davies R, Minhas S, Jayasena CN. The role of seminal reactive oxygen species assessment in the setting of infertility and early pregnancy loss. World J Urol. (2023) 41: 3257–65. doi: doi:10.1007/s00345-023-04472-2
  17. 17 Stavros S, Potiris A, Molopodi E, Mavrogianni D, Zikopoulos A, Louis K. Sperm DNA fragmentation: Unraveling its imperative impact on male infertility based on recent evidence. Int J Mol Sci. (2024) 25: 10167. doi: doi:10.3390/ijms251810167
  18. 18 Zikopoulos A, Christopoulos P, Kalampokas T, Gerede A, Moustakli E, Arkoulis I. Oxidative stress and inflammatory biomarkers in male infertility: A narrative review of diagnostic value and clinical integration. Diagnostics (Basel). (2026) 16: 527. doi: doi:10.3390/diagnostics16040527
  19. 19 Borges E, Braga DPAF, Zanetti BF, Iaconelli A, Setti AS. Revisiting the impact of ejaculatory abstinence on semen quality and intracytoplasmic sperm injection outcomes. Andrology. (2019) 7: 213–9. doi: doi:10.1111/andr.12572
  20. 20 Sørensen F, Melsen LM, Fedder J, Soltanizadeh S. The influence of male ejaculatory abstinence time on pregnancy rate, live birth rate and DNA fragmentation: A systematic review. J Clin Med. (2023) 12: 2219. doi: doi:10.3390/jcm12062219
  21. 21 Du C, Li Y, Yin C, Luo X, Pan X. Association of abstinence time with semen quality and fertility outcomes: a systematic review and dose-response meta-analysis. Andrology. (2024) 12: 1224–35. doi: doi:10.1111/andr.13583
  22. 22 Raditya M, Soejono AH, Siswanto MA, Atmoko W, Shah R, Agarwal A. Impact of shorter abstinence periods on semen parameters: A systematic review and meta-analysis. World J Mens Health. (2025) 43: 563–79. doi: doi:10.5534/wjmh.240035
  23. 23 Russo GI, Asmundo MG, Cocci A, Abdelhameed AS, Liprino A, Giacone F. Ejaculatory abstinence duration impacts semen parameters: Insights from a retrospective analysis in male infertility on 23,527 analyses. Front Endocrinol (Lausanne). (2025) 16: 1529262. doi: doi:10.3389/fendo.2025.1529262
  24. 24 Barratt CL, Björndahl L, Menkveld R, Mortimer D. ESHRE special interest group for andrology basic semen analysis course: a continued focus on accuracy, quality, efficiency and clinical relevance. Hum Reprod. (2011) 26: 3207–12. doi: doi:10.1093/humrep/der312
  25. 25 Sachdeva G, Vohra A, Ashraf M, Ravikumar D, Choudhary R. Impact of short-term abstinence on semen quality and oxidative stress in men with suboptimal semen parameters: A prospective observational study at a tertiary IVF centre. JBRA Assist Reprod. (2025) 30: 64–9. doi: doi:10.5935/1518-0557.20250159
  26. 26 Gonzalez DC, Ory J, Blachman-Braun R, Nackeeran S, Best JC, Ramasamy R. Advanced paternal age and sperm DNA fragmentation: A systematic review. World J Mens Health. (2022) 40: 104–15. doi: doi:10.1016/j.fertnstert.2021.07.952
  27. 27 Kold Rasmussen JM, Riise Dalgaard MI, Alipour H, Dardmeh F, Christiansen OB. Seminal oxidative stress and sperm DNA fragmentation in men from couples with infertility or unexplained recurrent pregnancy loss. J Clin Med. (2024) 13: 833. doi: doi:10.3390/jcm13030833
  28. 28 Yoshiakwa-Terada K, Takeuchi H, Tachibana R, Takayama E, Kondo E, Ikeda T. Age, sexual abstinence duration, sperm morphology, and motility are predictors of sperm DNA fragmentation. Reprod Med Biol. (2024) 23: e12585. doi: doi:10.1002/rmb2.12585
  29. 29 World Health Organization. WHO Laboratory Manual for the Examination and Processing of Human Semen. (2010). 5th ed. Geneva: World Health Organization, WHO Press.
  30. 30 Fernandez JL, Muriel L, Goyanes V, Segrelles E, Gosalvez J, Enciso M. Simple determination of human sperm DNA fragmentation with an improved sperm chromatin dispersion test. Fertil Steril. (2005) 84: 833–42. doi: doi:10.1016/j.fertnstert.2004.11.089
  31. 31 Santi D, Spaggiari G, Simoni M. Sperm DNA fragmentation index as a promising predictive tool for male infertility diagnosis and treatment management - meta-analyses. Reprod Biomed Online. (2018) 37: 315–26. doi: doi:10.1530/endoabs.56.gp214
  32. 32 Agarwal A, Majzoub A, Baskaran S, Panner Selvam MK, Cho CL, Henkel R. Sperm DNA fragmentation: A new guideline for clinicians. World J Mens Health. (2020) 38: 412–71. doi: doi:10.5534/wjmh.200128
  33. 33 Esteves SC, Zini A, Coward RM, Evenson DP, Gosálvez J, Lewis SEM. Sperm DNA fragmentation testing: Summary evidence and clinical practice recommendations. Andrologia. (2021) 53: e13874. doi: doi:10.1111/and.13874
  34. 34 Agarwal A, Panner Selvam MK, Arafa M, Okada H, Homa S, Killeen A. Multi-center evaluation of oxidation-reduction potential by the MiOXSYS in males with abnormal semen. Asian J Androl. (2019) 21: 565–9. doi: doi:10.4103/aja.aja_5_19
  35. 35 Ayad BM, Van der Horst G, Du Plessis SS. Revisiting the relationship between the ejaculatory abstinence period and semen characteristics. Int J Fertil Steril. (2018) 11: 238–46. doi: doi:10.1016/j.fertnstert.2004.11.089
  36. 36 Baldi E, Gallagher MT, Krasnyak S, Kirkman-Brown J. Extended semen examinations in the sixth edition of the WHO Laboratory Manual for the Examination and Processing of Human Semen: contributing to the understanding of the function of the male reproductive system. Fertil Steril. (2022) 117: 252–7. doi: doi:10.1016/j.fertnstert.2021.11.034
  37. 37 Farkouh A, Saleh R, Shah R, Agarwal A. Sperm DNA fragmentation in male infertility: From bench to bedside. Arab J Urol. (2023) 21: 199–203. doi: doi:10.1080/20905998.2023.2278200
  38. 38 Okubo T, Onda N, Hayashi T, Kobayashi T, Omi K, Segawa T. Performing a sperm DNA fragmentation test in addition to semen examination based on the WHO criteria can be a more accurate diagnosis of IVF outcomes. BMC Urol. (2023) 23: 78. doi: doi:10.1186/s12894-023-01257-y
  39. 39 Andrabi SW, Ara A, Saharan A, Jaffar M, Gugnani N, Esteves SC. Sperm DNA fragmentation: causes, evaluation and management in male infertility. JBRA Assist Reprod. (2024) 28: 306–19. doi: doi:10.5935/1518-0557.20230076
  40. 40 Araújo Câmara FE, de Sousa Sobral D, Lira Neto FT, Esteves SC, Borges Cavalcante M. Seminal oxidative stress and recurrent pregnancy loss: a systematic review and meta-analysis. Reprod Biomed Online. (2025) 51: 104873. doi: doi:10.1016/j.rbmo.2025.104873
  41. 41 Vitthala S, Nedelcu S, El-Toukhy T, Maheshwari A. Value of sperm DNA fragmentation (SDF) in predicting reproductive outcomes - a systematic review and meta-analysis. Hum Fertil (Camb). (2026) 29: 2618228. doi: doi:10.1080/14647273.2026.2618228
  42. 42 Wan B, Fu Y, Ma N, Zhou Z, Lu W. Sperm DNA fragmentation and assisted reproduction: an umbrella meta-analysis. Eur J Med Res. (2026) 31: 218. doi: doi:10.1186/s40001-025-03801-y
  43. 43 Llácer J, Requena A, Checa MA, Bellver J, Bosch E, Espinós JJ. The role of sperm DNA fragmentation in reproduction: a SWOT analysis. J Assist Reprod Genet. (2025) 42: 3633–53. doi: doi:10.1007/s10815-025-03645-9
  44. 44 Ayad B, Omolaoye TS, Louw N, Ramsunder Y, Skosana BT, Oyeipo PI. Oxidative stress and male infertility: Evidence from a research perspective. Front Reprod Health. (2022) 4: 822257. doi: doi:10.3389/frph.2022.822257
  45. 45 Jiang Y, Zhu Y, Kong Q, Lv X, Xi Q, Yu Y. Association between penultimate ejaculatory abstinence and sperm quality: a cross-sectional study. Front Endocrinol (Lausanne). (2024) 15: 1490399. doi: doi:10.3389/fendo.2024.1490399
  46. 46 Yao G, Qi Q, Dou X, Zhou W, Bai S, Zhang X. Association of abstinence time with semen quality in men who undergoing fertility evaluation: a cross-sectional study from 3052 participants. Front Endocrinol (Lausanne). (2025) 16: 1472333. doi: doi:10.3389/fendo.2025.1472333
  47. 47 Lo Giudice A, Asmundo MG, Cimino S, Cocci A, Falcone M, Capece M. Effects of long and short ejaculatory abstinence on sperm parameters: a meta-analysis of randomized-controlled trials. Front Endocrinol (Lausanne). (2024) 15: 1373426. doi: doi:10.3389/fendo.2024.1373426
  48. 48 Mayorga-Torres BJM, Camargo M, Agarwal A, du Plessis SS, Cadavid AP, Cardona Maya WD. Influence of ejaculation frequency on seminal parameters. Reprod Biol Endocrinol. (2015) 13: 47. doi: doi:10.1186/s12958-015-0045-9
  49. 49 Sanghvi K, Dean R, Nakagawa S, Reinhardt K, Sepil I, Vega-Trejo R. Sperm storage causes sperm senescence in human and non-human animals. Proc Biol Sci. (2026) 293: 20253181. doi: doi:10.1098/rspb.2025.3181
  50. 50 Sikka SC, Rajasekaran M, Hellstrom WJ. Role of oxidative stress and antioxidants in male infertility. J Androl. (1995) 16: 464–8. doi: doi:10.1002/j.1939-4640.1995.tb00566.x
  51. 51 Riffo MS, Parraga M. Study of the acrosome reaction and the fertilizing ability of hamster epididymal cauda spermatozoa treated with antibodies against phospholipase A2 and/or lysophosphatidylcholine. J Exp Zool. (1996) 275: 459–68. doi: doi:10.1002/(sici)1097-010x(19960815)275:6<459::aid-jez8>3.0.co;2-n
  52. 52 Wang Y, Fu X, Li H. Mechanisms of oxidative stress-induced sperm dysfunction. Front Endocrinol (Lausanne). (2025) 16: 1520835. doi: doi:10.3389/fendo.2025.1520835
  53. 53 Esterbauer H. Cytotoxicity and genotoxicity of lipid-oxidation products. Am J Clin Nutr. (1993) 57 (5 Suppl): 779S–86S. doi: doi:10.1093/ajcn/57.5.779s
  54. 54 Luczaj W, Skrzydlewska E. DNA damage caused by lipid peroxidation products. Cell Mol Biol Lett. (2003) 8: 391–413.
  55. 55 Henkel R. Leukocytes and oxidative stress: dilemma for sperm function and male fertility. Asian J Androl. (2011) 13: 43–52. doi: doi:10.1038/aja.2010.76
  56. 56 Levitas E, Lunenfeld E, Weiss N, Friger M, Har-Vardi I, Koifman A. Relationship between the duration of sexual abstinence and semen quality: analysis of 9,489 semen samples. Fertil Steril. (2005) 83: 1680–6. doi: doi:10.1016/j.fertnstert.2004.12.045
  57. 57 De Jonge C, LaFromboise M, Bosmans E, Ombelet W, Cox A, Nijs M. Influence of the abstinence period on human sperm quality. Fertil Steril. (2004) 82: 57–65. doi: doi:10.1016/j.fertnstert.2004.03.014
  58. 58 Akhigbe RE, Hamed MA, Dutta S, Sengupta P. Influence of ejaculatory abstinence period on semen quality of 5165 normozoospermic and oligozoospermic Nigerian men: A retrospective study. Health Sci Rep. (2022) 5: e722. doi: doi:10.1002/hsr2.722
  59. 59 Shen ZQ, Shi B, Wang TR, Jiao J, Shang XJ, Wu QJ. Characterization of the sperm proteome and reproductive outcomes with in vitro fertilization after a reduction in male ejaculatory abstinence period. Mol Cell Proteomics. (2019) 18 (Suppl 1): S109–17. doi: doi:10.1074/mcp.ra117.000541
  60. 60 Barbagallo F, Cannarella R, Crafa A, La Vignera S, Condorelli RA, Manna C. The impact of a very short abstinence period on assisted reproductive technique outcomes: A systematic review and meta-analysis. Antioxidants (Basel). (2023) 12: 752. doi: doi:10.3390/antiox12030752
  61. 61 Wouters K, Mateizel I, Van Asbroeck J, Schoemans C, Abraham M, Krunic M. Short ejaculatory abstinence time of 2 hours results in higher pregnancy outcomes compared to the recommended abstinence period of 2-7 days. Hum Reprod. (2024) 39 (Suppl 1): i228. doi: doi:10.1093/humrep/deae108.457
  62. 62 Vaughan DA, Tirado E, Garcia D, Datta V, Sakkas D. DNA fragmentation of sperm: a radical examination of the contribution of oxidative stress and age in 16 945 semen samples. Hum Reprod. (2020) 35: 2188–96. doi: doi:10.1093/humrep/deaa159
  63. 63 Nago M, Arichi A, Omura N, Iwashita Y, Kawamura T, Yumura Y. Aging increases oxidative stress in semen. Investig Clin Urol. (2021) 62: 233–8. doi: doi:10.4111/icu.20200066
  64. 64 Donatti LM, Martello CL, Andrade GM, Oliveira NP, Frantz N. Advanced paternal age affects the sperm DNA fragmentation index and may lead to lower good-quality blastocysts. Reprod Sci. (2023) 30: 2489–94. doi: doi:10.1007/s43032-023-01209-9
  65. 65 Simon L, Liu L, Murphy K, Ge S, Hotaling J, Aston KI. Comparative analysis of three sperm DNA damage assays and sperm nuclear protein content in couples undergoing assisted reproduction treatment. Hum Reprod. (2014) 29: 904–17. doi: doi:10.1093/humrep/deu040
  66. 66 Sallam N, Hegab M, El-Omda F, El-Kaffash D. Effect of oxidative stress in semen, follicular fluid, and embryo culture medium on the outcome of assisted reproduction. AIMJ. (2021) 2: 59–65. doi: doi:10.21608/aimj.2021.79536.1495
  67. 67 Henkel R, Morris A, Vogiatzi P, Saleh R, Sallam H, Boitrelle F. Predictive value of seminal oxidation-reduction potential (ORP) analysis for reproductive outcomes of intracytoplasmic sperm injection (ICSI) cycles. Reprod Biomed Online. (2022) 45: 1007–20. doi: doi:10.1093/humrep/deac105.034
  68. 68 Niu J, Chang Q, Xu J, Li J, Liu W, Chen Z. Relationship of the levels of reactive oxygen species in the fertilization medium with the outcome of in vitro fertilization following brief incubation. Front Endocrinol. (2023) 14: 1133566. doi: doi:10.3389/fendo.2023.1133566
  69. 69 Xie H, Chen Y, Xu S, Miao N, Zheng W, Jiang C. Increasing age in men is negatively associated with sperm quality and DNA integrity but not pregnancy outcomes in assisted reproductive technology. Front Aging. (2025) 6: 1603916. doi: doi:10.3389/fragi.2025.1603916
  70. 70 Comar VA, Petersen CG, Mauri AL, Mattila M, Vagnini LD, Renzi A. Influence of the abstinence period on human sperm quality: analysis of 2,458 semen samples. JBRA Assist Reprod. (2017) 21: 306–12. doi: doi:10.5935/1518-0557.20170052
  71. 71 Xi Q, Kong Q, Lv X, Dai R, Yu Y. Impact of ejaculation frequency on semen parameters and DNA fragmentation: a cross-sectional study. Reprod Biol Endocrinol. (2025) 23: 100. doi: doi:10.1186/s12958-025-01439-3
  72. 72 Chen GX, Li HY, Lin YH, Huang ZQ, Huang PY, Da LC. The effect of age and abstinence time on semen quality: a retrospective study. Asian J Androl. (2022) 24: 73–7. doi: doi:10.4103/aja202165
  73. 73 Samplaski MK, Dimitromanolakis A, Lo KC, Grober ED, Mullen B, Garbens A. The relationship between sperm viability and DNA fragmentation rates. Reprod Biol Endocrinol. (2015) 13: 42. doi: doi:10.1186/s12958-015-0035-y
  74. 74 Muratori M, Tarozzi N, Carpentiero F, Danti S, Perrone FM, Cambi M. Sperm selection with density gradient centrifugation and swim up: effect on DNA fragmentation in viable spermatozoa. Sci Rep. (2019) 9: 7492. doi: doi:10.1038/s41598-019-43981-2

Citation

Henkel, R., et al. (2026). Association of sperm DNA fragmentation with abstinence duration, seminal oxidative stress and age: a call to consider abstinence in andrological diagnostics. Frontiers in Urology, Volume 6. https://doi.org/
Received
Accepted
Published
Volume
6 - 2026

Copyright

Copyright © 2026 Henkel, Arafa, Majzoub, El Bardisi and Das.

License: https://creativecommons.org/licenses/by/4.0/

*Correspondence: Ralf Henkel

Article metrics

Views
0
Downloads
0
Citations
0
Shares
0